Long-term outcome of internal sphincter myectomy in patients with internal anal sphincter achalasia
Authors:
- 13 August 2009
- journal article
- research article
- Published by Springer Nature in Pediatric Surgery International
- Vol. 25 (10) , 869-871
Abstract
Background Internal anal sphincter achalasia (IASA) is a condition with presentation similar to Hirschsprung’s disease (HD), but with the presence of ganglion cells on rectal suction biopsy (RSB). The diagnosis is made on anorectal manometry (ARM) by the absence of the rectosphincteric reflex on rectal balloon inflation. Internal sphincter myectomy (ISM) is the treatment of choice for patients with IASA. Recently, botulinum toxin has been used to treat IASA patients. The purpose of this study was to assess the long-term bowel function in patients with IASA following ISM. Methods The medical records of 24 patients with IASA managed by ISM during 1993–2005 were examined. There were 18 boys and 6 girls, aged 2–12 years. All patients presented with intractable constipation with or without soiling. The diagnosis was made by the demonstration of the absence of the rectosphincteric reflex on ARM. HD was excluded by the presence of ganglion cells and normal acetylcholinesterase activity in RSB. Patients were followed 4–14 years later. Results Fifteen (62.5%) patients at the time of follow-up had regular bowel motions without the use of laxatives. Six (25%) patients had regular bowel motions, but remained on small doses of laxatives. Two (8.3%) patients who suffered from constipation and soiling required twice weekly enemas to remain clean. One (4.2%) patient required resection of dilated rectosigmoid colon 3 years after myectomy, remains on laxatives, but has normal bowel control. No patients had faecal incontinence following ISM. Conclusion This long-term follow-up study shows that the vast majority of IASA patients have normal bowel control following ISM.Keywords
This publication has 9 references indexed in Scilit:
- Role of rectal biopsy in predicting response to intrasphincteric botulinum toxin injection for obstructive symptoms after a pullthrough operation.2008
- Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunctionPediatric Surgery International, 2008
- Hirschsprung's Disease and Allied Disorders2008
- Long-term outcome after internal sphincter myectomy for internal sphincter achalasiaPediatric Surgery International, 2004
- Distribution of interstitial cells of Cajal in the internal anal sphincter of patients with internal anal sphincter achalasia and Hirschsprung disease.Archives of Pathology & Laboratory Medicine, 2003
- The treatment of internal anal sphincter achalasia with botulinum toxinPediatric Surgery International, 2001
- Internal anal sphincter achalasia: Outcome after internal sphincter myectomyJournal of Pediatric Surgery, 2001
- Altered intramuscular innervation and synapse formation in internal sphincter achalasiaPediatric Surgery International, 1999
- Absence of NADPH-Diaphorase Activity in Internal Anal Sphincter (IAS) AchalasiaJournal of Pediatric Gastroenterology and Nutrition, 1995